Welcome : Guest

Biomerieux S.A. (France) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Biomerieux S.A., which is principally a Biotechnology Company. Illustrated with 124 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-02686
Price: $3500
Company Type: Public
Pages: 132
Date: February 2017
Market Data Tables: 124

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Biomerieux S.A.'s Sales by Business Segment Worldwide (2014-2015) in Percentage for Clinical Applications (Microbiology, Immunoassays, and Molecular Biology), Industrial Applications, and Others......8
Table 2: Biomerieux S.A.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Europe, Americas (North America, and Latin America), and Asia-Pacific......9
Table 3: Biomerieux S.A.’s Sales by Business Segment Worldwide (2014) in Percentage for Clinical Applications (Microbiology, Immunoassays, Molecular Biology and Other Lines) and Industrial Applications......10
Table 4: Biomerieux S.A.’s Sales by Geographic Region Worldwide (2014) in Percentage for Europe, Middle East, Africa, Americas and Asia-Pacific......11
Blood Screening Tests......12
Table 5: Blood Screening Test Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Commercial West Nile Virus, Tigris/Spare Parts to Chiron at Cost, Ultrio/Procleix Blood Screening, and Others......12
Cervical Screening......13
Table 6: Cervical Screening Market by Test Type in Canada (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......13
Table 7: Cervical Screening Market by Test Type in Japan (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......14
Table 8: Cervical Screening Market by Test Type in the US (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......15
Gram-Negative Bloodstream Infections Tests......16
Table 9: Gram-Negative Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......16
Gram-Positive Bloodstream Infections Tests......17
Table 10: Gram-Positive Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......17
Clinical Laboratory Testing......18
Table 11: Clinical Laboratory Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Laboratory Corporation of America Holdings, Quest Medical, Inc., Physician Office, Hospital Affiliated, and Others......18
Clinical NGS Based Diagnostics Tests......19
Table 12: Clinical NGS Based Diagnostics Test market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Exome, Targeted Panels and Others......19
Clostridium Difficile Tests......20
Table 13: Clostridium Difficile Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......20
Diagnostic Testing......21
Table 14: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......21
Table 15: Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs*, Physician Office Labs and Others......22
Table 16: Diagnostics Tests Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......23
Table 17: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......24
Table 18: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......25
Table 19: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......26
Table 20: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......27
Table 21: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......28
Ambulatory Physician Diagnostics Testing Services......29
Table 22: Ambulatory Physician Diagnostics Testing Services Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, POLs, and Others......29
Hospital Diagnostics Testing Services......30
Table 23: Hospital Diagnostics Testing Services Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Outpatient, and Inpatient......30
DNA Carrier Testing......31
Table 24: DNA Carrier Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......31
Forensics Testing......32
Table 25: Forensics Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value for DNA, Fingerprints, and Others......32
Genetic Testing......33
Table 26: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......33
Table 27: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......34
Table 28: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......35
Oncology Genomics......36
Table 29: Oncology Genomics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......36
Table 30: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......37
Table 31: Oncology Genomics Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......38
HLA (Human Leukocyte Antigen) Testing......39
Table 32: Human Leukocyte Antigen (HLA) Testing Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......39
Table 33: Human Leukocyte Antigen (HLA) Tests Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume Sales for US, and Others......40
Table 34: Human Leukocyte Antigen (HLA) Tests Price Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......41
In Vitro Diagnostics (IVD)......42
Table 35: Global IVD Market (2014) in US$ Million......42
Table 36: In-Vitro Diagnostics (IVD) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry, Hematology and Coagulation, Histology and Cytology, Immunoassays, Molecular Diagnostics, Point of Care and Others......43
Table 37: Global In Vitro Diagnostics (IVD) Market by Area (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......44
Table 38: In Vitro Diagnostics (IVD) Market by Disease Type Worldwide (2015) - Percentage Breakdown by Value for Cancers, Cardio-Vascular Diseases, Infective Diseases, and Others......45
Table 39: In Vitro Diagnostics (IVD) Market by Product Category Worldwide (2015) - Percentage Breakdown by Value for Instrumentation, and Reagents......46
Table 40: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......47
Table 41: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......48
Table 42: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......49
Table 43: In-Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, United States and Others......50
Table 44: In-Vitro Diagnostics Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and others......51
Table 45: In-Vitro Diagnostic Products Market by Segment in China (2015) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......52
Table 46: In Vitro Diagnostics (IVD) Market by Region in Europe (2015) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of Europe......53
Table 47: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2015) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......54
Table 48: In Vitro Diagnostics (IVD) Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose......55
Clinical In-Vitro Diagnostics......56
Table 49: Clinical In-Vitro Diagnostics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan, United States, and Rest of World......56
Table 50: Clinical In-Vitro Diagnostics Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Cancers, Infectious Diseases and Others......57
In-Vitro Diagnostics Devices......58
Table 51: In-Vitro Diagnostics Devices Market by Product in China (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Hematology Analyzer, Immuno Assay, and Others......58
In Vitro Diagnostics (IVD) Laboratories......59
Table 52: In-Vitro Diagnostics (IVD) Laboratory Services Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospital Labs, Physician Office Labs, Other Independent Labs and Others*......59
Table 53: In Vitro Diagnostics (IVD) Laboratory Market by Customer in France (2015) - Percentage Share Breakdown by Value Sales for Etablissement Français du Sang (EFS), Private Laboratories, Public and Private Hospitals, and Others......60
In Vitro Diagnostics (IVD) Reagents......61
Table 54: In Vitro Diagnostics (IVD) Reagents Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Biochemistry, Genetic Tests, Haematology, Immunochemistry, Infectious Immunology, and Microbiology......61
Molecular Diagnostics......62
Table 55: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......62
Table 56: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......63
Table 57: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......64
Table 58: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......65
Table 59: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......66
Table 60: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......67
Table 61: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......68
Table 62: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......69
Table 63: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......70
Table 64: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......71
Table 65: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......72
Table 66: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......73
Table 67: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......74
Table 68: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Others......75
Table 69: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......76
Table 70: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......77
Table 71: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......78
Table 72: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......79
Table 73: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......80
Table 74: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......81
Molecular Cystic Fibrosis (CF) Testing......82
Table 75: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......82
Molecular Infectious Disease Testing......83
Table 76: Molecular Infectious Disease Market by Panel Worldwide (2015) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......83
Table 77: Molecular Infectious Disease Diagnostic Equipment Market by Platform Worldwide (2015) - Percentage Share Breakdown by Value Sales for BioFire, LX 100/200 & MAGPIX, MALDI Biotyper, Verigene, XT-8, and Others......84
Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing......85
Table 78: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market by Type in the US (2015) - Percentage Share Breakdown by Value Sales for Chromogenic Media, Conventional Media, GeneXpert, GneOhm, LightCycler and Molecular Diagnostics Laboratory-Developed Test (MDX LDT)......85
Molecular Monitoring Oncology......86
Table 79: Molecular Monitoring Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......86
Pathogen Testing......87
Table 80: Pathogen Testing Market by Category in North America (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......87
Table 81: Pathogen Testing Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume for Escherichia Coli, Listeria, Salmonella, and Others......88
Table 82: Pathogen Testing Market by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Culture, Immunochemical, and Molecular......89
Table 83: Pathogen Testing Market by Category in Asia (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Convenience, Molecular, and Traditional......90
Table 84: Pathology Market by Service Benefit in Australia (2015) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......91
Table 85: Pathology Market by Service in Australia (2015) - Percentage Share Breakdown by Value Sales for Esoteric Services and Routine Services......92
Table 86: Pathogen Testing Market by Category in European Union (EU) (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......93
Respiratory Virus Tests......94
Table 87: Respiratory Virus Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......94
Neonatal Screening Test‎......95
Table 88: Neonatal Screening Test‎ Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......95
Next-Generation Sequencing (NGS)......96
Table 89: Next-Generation Sequencing (NGS) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Library Preparation and Other Sample Preparations......96
Table 90: Global NGS Applications (2015) - Percentage Breakdown of Usage Share by End-Uses - Human Genome Research; Clinical Service Providers; Microorganisms, Plant and Animal Genetic Analysis and Molecular Diagnostics......97
Table 91: NGS Sequencing Market in North America (2014) - Percentage Share Breakdown by leading Players - Illumina/Solexa; Life Technologies, Roche/454, and Helicos......98
Table 92: Next Generation Sequencing Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Exome, Targeted Panels, Whole Genome, and Others......99
Non-Invasive Prenatal Testing (NIPT)......100
Table 93: Non-Invasive Prenatal Testing (NIPT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......100
Food Testing......101
Table 94: Food Testing Market by Location in North America (2015) - Percentage Share Breakdown by Volume for Food Processor Companies, and Third Party Contract Testing Labs......101
Table 95: Food Testing Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Chemical Contaminants, Indicator Organism, and Pathogen......102
Viral Load Testing......103
Table 96: Viral Load Testing Market Worldwide (2015-2020) in '000......103
Table 97: Viral Load Testing Market by Instrument Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cobas AMPLICOR, Cobas TaqMan, Versant, NucliSENS, and Others......104
Blood Screening Tests......105
Table 98: Market Shares of Leading Blood Screening Test Companies by Value Sales Worldwide (2015) - Percentage Breakdown for F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......105
Cancer Genetic Diagnostics Reference Laboratory......106
Table 99: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......106
Clinical Laboratories......107
Table 100: Market Shares of Leading Clinical Laboratories in the US (2015) - Percentage Breakdown by Value Sales for Laboratory Corporation of America Holdings, Physician Office Partners, Inc., Quest Diagnostics Incorporated, and Others......107
Clinical Testing......108
Table 101: Market Shares of Leading Clinical Testing Service Providers in Japan (2015) - Percentage Breakdown by Value for BML, Inc., Falco Biosystems Ltd., Mitsubishi Chemical Medience Corporation, Special Reference Laboratories, Inc., and Others......108
Table 102: Market Shares of Leading Clinical Testing Service Providers Worldwide (2015) - Percentage Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics, Inc., and Others......109
Diagnostic Testing......110
Table 103: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......110
Human Papillomavirus (HPV) Testing......111
Table 104: Market Shares of Leading Human Papillomavirus (HPV) Testing Companies Worldwide (2015) - Percentage Breakdown by Value for F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., and Others......111
Table 105: Market Shares of Leading Human Papillomavirus (HPV) Testing Companies in China (2015) - Percentage Share Breakdown by Value for Chaozhou Kaipu Biochemistry Co., Ltd., Mingyuan Medicare Development Co., Ltd., Qiagen China (Shanghai) Co., Ltd. (Digene), Yaneng Bioscience (Shenzhen) Co., Ltd., and Others......112
In Vitro Diagnostics (IVD)......113
Table 106: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......113
Table 107: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others......114
Table 108: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others*......115
Table 109: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others......116
Table 110: Market Shares of Leading In-Vitro Diagnostics (IVD) Product Developers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Beckman Coulter, Inc., Johnson & Johnson, Roche Molecular Systems, Inc., Siemens AG and Others......117
Table 111: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......118
Table 112: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......119
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing......120
Table 113: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., and Qiagen NV......120
Molecular Clostridium Difficile (C. Diff) Testing......121
Table 114: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......121
Pathogen Testing Equipment......122
Table 115: Market Shares of Leading Pathogen Testing Equipment Brands Worldwide (2014) - Percentage Share Breakdown by Value for 3M Petrifilm, BioMerieux VIDAS, DuPont BAX, and Others......122
STD Testing......123
Table 116: Market Shares of Leading STD Testing Companies by Value Sales Worldwide (2015) - Percentage Breakdown for Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......123
Urine Test/Kit......124
Table 117: Market Shares of Leading Urine Test/Kit Brands through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart) Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Azo Test Strips, Uristat, and Others......124
Food Testing Equipment......125
Table 118: Market Shares of Leading Food Testing Equipment Manufacturers Worldwide (2015) - Percentage Breakdown by Value for 3M and Biotrace, BioMerieux (incl. AES Laboratoire Groupe SA), Neogen Corporation, Thermo Fisher Scientific, Inc., and Others......125
Table 119: BioMérieux SA’s Sales by Activity Worldwide (2015) - Percentage Market Share Breakdown by Value for Immund, Industrial Applications, Microbiology, Molecular Biology, and Others......126
Table 120: BioMérieux SA’s Sales by Geographic Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Asia-Pacific, France, Latin America, North America, Rest of Europe, Middle East and Africa (MEA), Southern Europe, and Western Europe......127
Table 121: BioMerieux's Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Asia-Pacific, Latin America, North America, Western Europe, and Others......128
Table 122: BioMerieux's Sales by Product Worldwide (2015) - Percentage Market Share Breakdown by Value for Consumables, Instruments, and Others......129
Table 123: Biomerieux S.A.’s Sales by Geographic Region Worldwide (2013) in Percentage for Europe, North America, Asia-Pacific, Latin America and R&D-Related Revenue......130
Table 124: Biomerieux S.A.’s Sales by Business Segment Worldwide (2013) in Percentage for Clinical Applications, Industrial Applications and R&D-Related Revenue......131